Asthma Insurance Claim Denied in New Jersey? Fight Back With DOBI and NJ FamilyCare

New Jersey — particularly cities like Newark, Camden, Paterson, and Trenton — carries one of the heaviest asthma burdens in the United States. Industrial pollution, diesel truck traffic from port operations, and aging housing stock make severe asthma a daily reality for hundreds of thousands of New Jerseyans. If your insurer has denied asthma treatment, New Jersey's regulatory framework gives you strong tools to fight back.

Why New Jersey Insurers Deny Asthma Claims

Common denial patterns in New Jersey:

• Step therapy for biologics: Insurers require patients to fail on multiple controller medications before approving Dupixent, Fasenra, Nucala, or Tezspire
• Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization denials for nebulizers: Home nebulizers denied as duplicative or not medically necessary alongside inhaler prescriptions
• Rescue inhaler frequency limits: Albuterol restricted even for patients with multiple exacerbations monthly
• Out-of-network specialist denials: Narrow network plans, particularly in Camden and southern NJ, exclude many allergists and pulmonologists
• Biologic eosinophil threshold disputes: Insurers apply stricter criteria than FDA labeling supports

New Jersey Insurance Regulator: DOBI

The New Jersey Department of Banking and Insurance (DOBI) regulates health insurers in New Jersey and handles External Independent Review: Complete Guide" class="auto-link">external review requests.

DOBI Consumer Hotline:

• Phone: 1-800-446-7467
• Website: state.nj.us/dobi
• File a complaint: state.nj.us/dobi/consumer.htm

New Jersey law requires health plans to offer external review for adverse benefit determinations. External review decisions are binding on the insurer. Standard external reviews are completed within 45 days; expedited reviews within 72 hours for urgent clinical situations.

NJ FamilyCare and Asthma Biologics

NJ FamilyCare is New Jersey's combined Medicaid and CHIP program, providing coverage for low-income families, children, pregnant women, seniors, and people with disabilities. NJ FamilyCare is delivered through managed care organizations including Horizon Blue Cross Blue Shield of NJ (NJ FamilyCare), Aetna Better Health of NJ, UnitedHealthcare Community Plan, and Wellcare by Allwell.

For NJ FamilyCare denials:

• File a grievance with your managed care plan within 90 days of denial
• Request a State Fair Hearing through DMAHS: 1-800-792-9773
• Contact Community Health Law Project: chlp.org — free legal help for NJ residents
• Contact Legal Services of New Jersey: lsnj.org — statewide free legal assistance

NJ FamilyCare covers FDA-approved asthma biologics for eligible members with prior authorization. Documentation requirements include confirmed severe asthma diagnosis, eosinophil counts where applicable, prior therapy failures, and specialist attestation.

Newark, Camden, and NJ's Asthma Crisis

Newark's asthma hospitalization rate has been nearly 4 times the state average, driven by the Port Newark diesel truck corridor, the NJ Turnpike extension, and Linden refinery emissions. Camden — once listed as one of America's most polluted cities — has high asthma rates among children and adults living near industrial facilities in an environmental justice area.

For patients in these communities, the public health documentation of air quality harms can directly support a medical necessity argument. Reference local air quality data from NJ DEP's air monitoring network (njairquality.org) in your appeal materials.

The NAACP New Jersey State Conference (naacpnj.org) and WE ACT for Environmental Justice have documented the racial dimension of this asthma burden. If you are a Black or Latino patient in an environmental justice community, this context strengthens your medical necessity argument by demonstrating ongoing, documented environmental exposure.

FDA-Approved Biologics for Severe Asthma: NJ Appeal Strategy

• Dupixent (dupilumab): Moderate-to-severe eosinophilic or OCS-dependent asthma. Particularly useful for NJ patients with coexisting eczema and nasal polyps — a common triad with severe asthma
• Fasenra (benralizumab): Severe eosinophilic asthma with documented eosinophil count
• Nucala (mepolizumab): Severe eosinophilic asthma; COPD with eosinophilic phenotype
• Tezspire (tezepelumab): Uncontrolled severe asthma — no eosinophil minimum, useful for patients in NJ's mixed-trigger environments
• Xolair (omalizumab): Allergic asthma confirmed by positive skin test or RAST and elevated total IgE

Include your eosinophil levels, IgE levels, spirometry results, ER visits and hospitalizations, and a complete prior treatment history with outcome documentation.

New Jersey's Step Therapy Protections

New Jersey law requires health insurers to grant step therapy exceptions when:

• The required medication is contraindicated for the patient
• The patient previously tried and failed the required medication
• The step therapy protocol would cause clinically significant harm
• The patient is stable on a different medication

Your physician should submit a formal step therapy exception request with clinical justification. Under New Jersey regulations, insurers must respond within 72 hours for standard requests and 24 hours for urgent cases.

Step-by-Step Appeal Process in New Jersey

1. Get denial in writing: EOB and denial letter with specific clinical rationale
2. Internal appeal: Submit within 60–180 days; include physician letter, lab values, treatment history
3. Peer-to-peer review: Physician contacts insurer's medical director
4. Step therapy exception request: Formal request citing NJ step therapy protections
5. External review through DOBI: After internal appeal exhaustion; binding on insurer
6. DOBI complaint: state.nj.us/dobi — complaints are investigated

New Jersey Advocacy Resources

• American Lung Association – New Jersey: lung.org | 1-800-586-4872
• NJ Breathe Easy Asthma Coalition: coordinated through NJ DOH
• Community Health Law Project: chlp.org — insurance dispute legal help
• Ironbound Community Corporation: ironboundcc.org — environmental health advocacy in Newark
• NAACP New Jersey: naacpnj.org — health equity advocacy

Fight Back With ClaimBack

New Jersey's asthma patients — many living in communities that have borne decades of industrial pollution — deserve access to the best available medical treatments. ClaimBack helps you build a compelling, legally grounded appeal that holds your insurer accountable under New Jersey law.

Start your appeal at ClaimBack — take the first step today.

Related Reading:

• How to Write an Insurance Appeal Letter
• Common Reasons Insurance Claims Are Denied
• Internal vs. External Insurance Appeal: Which Should You File?